EPCAM and cancer: 2.1. EpCAM-ReTARGTPRvIL2 and EpCAM-ReTARGTPRIFNαR149A Selectively Bind to EpCAMpos Cancer Cells, Whereupon Their Respective Cytokine Muteins Attain Enhanced Biological Activity